236 related articles for article (PubMed ID: 32037652)
1. The influence of Epstein-Barr virus and cytomegalovirus on childhood respiratory health: A population-based prospective cohort study.
van Meel ER; Jaddoe VWV; Reiss IKM; van Zelm MC; de Jongste JC; Moll HA; Duijts L
Clin Exp Allergy; 2020 Apr; 50(4):499-507. PubMed ID: 32037652
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus and cytomegalovirus are differentially associated with numbers of cytokine-producing cells and early atopy.
Nilsson C; Larsson Sigfrinius AK; Montgomery SM; Sverremark-Ekström E; Linde A; Lilja G; Blomberg MT
Clin Exp Allergy; 2009 Apr; 39(4):509-17. PubMed ID: 19055650
[TBL] [Abstract][Full Text] [Related]
3. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
[TBL] [Abstract][Full Text] [Related]
4. Does early EBV infection protect against IgE sensitization?
Nilsson C; Linde A; Montgomery SM; Gustafsson L; Näsman P; Blomberg MT; Lilja G
J Allergy Clin Immunol; 2005 Aug; 116(2):438-44. PubMed ID: 16083803
[TBL] [Abstract][Full Text] [Related]
5. Herpesvirus infections and allergic sensitization in children of families with anthroposophic and non-anthroposophic lifestyle - the ALADDIN birth cohort.
Hesla HM; Gutzeit C; Stenius F; Scheynius A; Dahl H; Linde A; Alm J
Pediatr Allergy Immunol; 2013 Feb; 24(1):61-5. PubMed ID: 23331530
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.
Sohlberg E; Saghafian-Hedengren S; Rasul E; Marchini G; Nilsson C; Klein E; Nagy N; Sverremark-Ekström E
J Immunol; 2013 Dec; 191(11):5669-76. PubMed ID: 24140645
[TBL] [Abstract][Full Text] [Related]
8. EBV VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children.
Sohn MJ; Cho JM; Moon JS; Ko JS; Yang HR
Medicine (Baltimore); 2018 Sep; 97(38):e12380. PubMed ID: 30235701
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological and Liver Biomarkers Profile of Epstein-Barr Virus Infection and Its Coinfection with Cytomegalovirus in Patients with Hematological Diseases.
Ferrari de Freitas L; de Melo Silva J; Nogueira Barbosa A; Miranda Santos E; Pinheiro-Silva R; Soares Pontes G
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439817
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults.
Levine H; Balicer RD; Rozhavski V; Halperin T; Shreberk M; Davidovitch N; Huerta-Hartal M; Ankol OE
Ann Epidemiol; 2012 Nov; 22(11):783-8. PubMed ID: 22831994
[TBL] [Abstract][Full Text] [Related]
11. Age at cytomegalovirus, Epstein Barr virus and varicella zoster virus infection and risk of atopy: The Born in Bradford cohort, UK.
Pembrey L; Waiblinger D; Griffiths P; Wright J
Pediatr Allergy Immunol; 2019 Sep; 30(6):604-613. PubMed ID: 31188509
[TBL] [Abstract][Full Text] [Related]
12. High incidence of Epstein-Barr virus, cytomegalovirus and human herpesvirus 6 infections in children with cancer.
Michálek J; Horvath R
BMC Pediatr; 2002; 2():1. PubMed ID: 11818028
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants.
Holder B; Miles DJ; Kaye S; Crozier S; Mohammed NI; Duah NO; Roberts E; Ojuola O; Palmero MS; Touray ES; Waight P; Cotten M; Rowland-Jones S; van der Sande M; Whittle H
PLoS One; 2010 Nov; 5(11):e14013. PubMed ID: 21103338
[TBL] [Abstract][Full Text] [Related]
14. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection and development of allergic diseases in early childhood: interaction with EBV infection?
Sidorchuk A; Wickman M; Pershagen G; Lagarde F; Linde A
J Allergy Clin Immunol; 2004 Dec; 114(6):1434-40. PubMed ID: 15577849
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.
Adjei AA; Armah HB; Gbagbo F; Boamah I; Adu-Gyamfi C; Asare I
BMC Infect Dis; 2008 Aug; 8():111. PubMed ID: 18706107
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells.
Saghafian-Hedengren S; Sohlberg E; Theorell J; Carvalho-Queiroz C; Nagy N; Persson JO; Nilsson C; Bryceson YT; Sverremark-Ekström E
J Virol; 2013 Dec; 87(24):13446-55. PubMed ID: 24089567
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder.
Gentile I; Zappulo E; Bonavolta R; Maresca R; Messana T; Buonomo AR; Portella G; Sorrentino R; Settimi A; Pascotto A; Borgia G; Bravaccio C
In Vivo; 2014; 28(4):621-6. PubMed ID: 24982232
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group.
Lang DJ; Kovacs AA; Zaia JA; Doelkin G; Niland JC; Aledort L; Azen SP; Fletcher MA; Gauderman J; Gjerset GJ
J Acquir Immune Defic Syndr (1988); 1989; 2(6):540-9. PubMed ID: 2555471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
